TickerKhojComparison · NSE · data 2026-11-02
Abbott India Limited vs Ajanta Pharma Limited
In plain words
Size: Abbott India Limited is about 1.2 times the market value of Ajanta Pharma Limited.
Return on equity: Abbott India Limited 34.5% vs Ajanta Pharma Limited 25.4%.
Profit growth over 3 years: Ajanta Pharma Limited 21.6% a year vs Abbott India Limited 17.8% a year.
Debt to equity: Ajanta Pharma Limited 0.06 vs Abbott India Limited 0.04.
Differences in the numbers, not a recommendation of either stock.
Side by side
| ABBOTINDIA | AJANTPHARM | |
|---|---|---|
| Price | ₹25,665 | ₹3,438.9 |
| Market cap | ₹54,384 cr | ₹43,891 cr |
| P/E | 33.8 | 34.1 |
| P/B | — | 8.8 |
| ROE | 34.5% | 25.4% |
| ROCE | 39.1% | 30.0% |
| Debt / equity | 0.04 | 0.06 |
| Operating margin | 27.5% | 25.4% |
| Dividend yield | 2.05% | 1.71% |
| Sales growth, 3 years (yearly) | 9.0% | 13.3% |
| Profit growth, 3 years (yearly) | 17.8% | 21.6% |
| 1-year return | -13.4% | 39.3% |
| Revenue, last 12 months | ₹7,004 cr | ₹6,217 cr |
| Net profit, last 12 months | ₹1,615 cr | ₹1,263 cr |
| Latest quarter | — | Sept 2026 |
| Quarter net profit | — | ₹388 cr |
| Quarter profit vs a year earlier | — | +49.2% |
| Promoter holding | — | 63.47% |
| Health check | Strong (7.2/10) | Strong (8.8/10) |
Common questions
Which has a higher P/E, Abbott India Limited or Ajanta Pharma Limited?
Ajanta Pharma Limited trades at the higher P/E (34.1 against 33.8). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Abbott India Limited (34.5% against 25.4%).
Which carries more debt?
Ajanta Pharma Limited has the higher debt-to-equity ratio (0.06 against 0.04).